DRUG-STUDY Group Case Study Nalbuphine
DRUG-STUDY Group Case Study Nalbuphine
DRUG STUDY
Patient:` C. Ano-os Age:34 Hospital No: Room No:_________
Impression Diagnosis: Attending Physician:_____________________________
Allergy to:_____________________________
Generic / Brand Name & Indication / Side Effects/ Adverse Nursing Responsibilities
Dosage Timing & Duration Patient Teaching
Classification Pharmacodynamics of Drug Reactions/ Contraindication (Nursing Process Approach)
(5%) (20%)
(5%) (20%) (10%) (40%)
Generic Name: Drug form & Dosage Indications: Side Effects: • Use nalbuphine cautiously • Warn patient no to take
Ordered: Moderate to severe pain Chest pain, difficulty with in patients taking other drug longer than
Nalbuphine (non-opioid tolerant patients, swallowing, fainting, redness drugs that can cause absolutely needed
IV, 10 mg/ml, 20 mg/ml adjunct to balanced of the face, neck, arms, and respiratory depression because excessive or
10 mg/amp anesthesia, preoperative and occasionally upper chest, • Keep resuscitation prolonged use can lead to
postoperative analgesia; convulsions, ireegular equipment and naloxone abuse, addiction, misuse,
Brand Name: obstetric analgesia during heartbeat, fever, dizziness, readily available at all overdose, and possibly
Timing: labor and delivery drowsiness,vomiting, times to reverse death
Nubain sleepiness, nausea, sweaty, nalbuphine’s effects, if • Counsel patient against
2-3 minutes, q5 (every 5 clampy skin, vertigo needed making important
hours) • Be aware during decisions while receiving
prolonged use, a stool drug because it may
Adverse Reaction: softener may be given to cloud her judgment
Classification Name: CNS: dizziness, headache, minimize constipation • Instruct patient to notify
Duration: sedation, vertigo all prescribers of opioid
Therapeutic Class: Opioid Pharmacodynamics: CV: bradycardia, hypotension use
analgesics 3 – 6 hours, x2 doses Nalbuphine is a kappa-opioid EENT: dry mouth
Pharmacologic Class: Opioid receptor and a partial mu- GI: nausea vomiting
Agonist – antagonist opioid receptor antagonist. Respiratory: respiratory
and opioid partial Analgesic properties are depression
agonist Other drug forms: mediated through agonist Skin: damminess, diaphoresis
activity at the kappa-opioid
receptor. Because of this
unique mixed agonist- Contraindications:
antagonist – opioid receptor Contraindicated in patients
activity of nalbuphine, it hypersensitive to drug or its
provides analgesic, with less components and in those
nausea, pruritus, and with significant respiratory
UNIVERSITY OF CEBU at PARDO and TALISAY, Inc.
BULACAO, CEBU CITY
TEL. NO. 272-8475 / 272-2985
College of Nursing
respiratory depression when depression, known or
compared to morphine suspected GI obstruction
(including paralytic ileus) and
acute severe asthma in an
unmonitored setting or the
absence of resuscitative
equipment.
_____________________________________ _______________________________
Printed Name & Signature of Clinical Instructor: Printed Name & Signature of Student: